Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 10 hours agoImmuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen Anastasiou has resigned from his position as Non-Executive ...
Elliott Epstein: Bully billionaire Bill Gates isn’t much better as a philanthropist
The Lewiston Sun Journal· 6 days agoIs there such a thing as a “good” billionaire? In his 2023 book, “The Bill Gates Problem,”...
InnovationRx: FDA Approves Abbott’s Dissolvable Stents
Forbes· 3 days agoInnovationRx is your weekly digest of healthcare news. Severe cases of this disease can lead to strokes and heart attacks or to a condition called critical limb ischemia, which can have an extremely ...
Women Need Better Treatments for Bacterial Vaginosis
Newswise· 3 days agoBALTIMORE, May 2, 2024: Bacterial Vaginosis (BV) affects about one-quarter of reproductive-age women and is linked to adverse health outcomes, such as increased HIV risk. Now, two European clinical ...
Robert F. Kennedy Jr. secures spot on California ballot
Courthouse News Service· 5 days agoKennedy said in a video released Monday afternoon that he and his running mate, patent attorney...
Investment Opportunities in the Drug Distribution Industry
Morningstar· 3 days agoThe market has rallied behind the US drug distribution industry recently because of the popularity of GLP-1s, easing generic drug deflation, and an increase in specialty asset investments. Drug ...
TFF Pharmaceuticals announces $4.8 million stock offering By Investing.com
Investing.com· 4 days agoTFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company, has launched a...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoTFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products ...
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Zacks· 3 days agoEli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
